Atlas Trials

Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC)

Clinical trial NCT04326920 · COMPLETED

Trial details

NCT number
NCT04326920
Sponsor
University Hospital, Ghent
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
COVID-19
Start date
2020-03-24
Primary completion
2020-09-28
Enrollment
87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.